Navigation Links
Aubrey Inc. Releases New Advanced Biosynthetic Wound Care Product 'AWBAT Plus'
Date:1/20/2011

CARLSBAD, Calif., Jan. 20, 2011 /PRNewswire/ -- Aubrey Inc. – http://www.aubreyinc.com – announced that after a successful soft release and product evaluation phase of its second generation product, AWBAT® Plus, it is now in full production and currently available for purchase.  Founder Aubrey Woodroof, PhD MBA, expresses his appreciation for being able to advance the art once again.  "It is a wonderful feeling to hear from a renowned surgeon that 'AWBAT® Plus has the potential to take wound coverage to the next level' and that it 'provides not only an optimal milieu but also a stimulus to promote active wound healing.'"

AWBAT® Plus utilizes the same patented technology for the precision-porous silicone-nylon membrane as the platform product, AWBAT®.  AWBAT® Plus, however, contains not only significantly more collagen but also chondroitin-4-sulfate, chondroitin-6-sulfate, vitamin C, vitamin E and Immuno-10 (activated mixture of polysaccharides from Aloe).  It was determined by FDA to be a combination product consisting of device components as well as drugs.  In subsequent laboratory testing, Immuno-10 was found to stimulate human dermal fibroblast proliferation, as well as fibroblast collagen and alpha-SMA production.  Human keratinocyte production was also enhanced by Immuno-10.  AWBAT® Plus is currently indicated for partial thickness burns, meshed autografts, and donor sites.

Woodroof stated: "We are very excited to have AWBAT® Plus now also available in our proprietary glove design.  Hand burns are common injuries and complex wounds to treat. The AWBAT® Plus Glove was designed specifically for ease of application and form fit, and to promote early mobility and rehabilitation, which is essential for maintaining functional dexterity and faster return to work."

Aubrey Inc. intends to seek clearance for use of AWBAT® Plus on chronic wounds this year.  Woodroof noted that in an investigator initiated evaluation of AWBAT® Plus on chronic wounds, the surgeon stated, "We have found AWBAT®-D Plus to be an effective alternative to Apligraf®, Dermagraft® and Integra® in preliminary observations of chronic wound management.  AWBAT®-D Plus can be used as an adjunct with NPWT."

About Aubrey Inc.

Dr. Aubrey Woodroof invented Biobrane® in 1978, an innovative product which revolutionized burn care.  In 2007, Woodroof came out of retirement to create the AWBAT® line as the next generation of advanced wound care technology.


'/>"/>
SOURCE Aubrey Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
2. CEL-SCI Corporation Releases Letter to Shareholders
3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
5. Immunosyn Corporation Releases SF-1019 Study Results
6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... CALABASAS, Calif. , June 14, 2017 ... with the City of Fremont ... chain of the bio-pharma industry in California ... sharing technology, enabling executive networking, and fostering workforce development. ... the development and growth of start-ups, as well as ...
(Date:6/11/2017)... -- Eli Lilly and Company (NYSE: LLY ) announced ... galcanezumab, an investigational treatment for the prevention of episodic ... secondary endpoints for galcanezumab compared to placebo at both ... and REGAIN) will be presented today at the American ... Boston . "The detailed Phase ...
(Date:6/8/2017)... , June 8, 2017  Less than a ... hit more than 200,000 companies, including hospital networks, in ... heralded as one of the largest online extortion attempts ... the healthcare market, it is imperative that providers understand ... their data from this — and many other very ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... 2017 , ... With a heatwave currently bearing down on Northern California pushing temperatures to the ... swimsuit ready is easy with laser hair removal. , The process of summer waxing ... routine when all you want to do is get out, dive in and cool off. ...
(Date:6/24/2017)... Tampa, Fla. (PRWEB) , ... June 24, 2017 ... ... Fla., is now offering genetic testing for medications in select Florida and Texas ... of pharmacogenomics. , This new application of genetic testing recognizes the role ...
(Date:6/24/2017)... York (PRWEB) , ... June 24, 2017 , ... ... the Dental365 family. Located at 217 Portion Road in Lake Ronkonkoma, Dental365 offers ... evenings and weekends so that visits to the dentist fit into their patients’ ...
(Date:6/24/2017)... , ... June 24, 2017 , ... Doorknobs are for ... security, such as getting a guard dog or having an alarm system installed. But ... secure against forced entry. Yair Frenkel, owner of TX Premier Locksmith in Killeen, TX ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... is needed and will ultimately do significant harm to people with all chronic ... , "While it leaves in place the Affordable Care Act (ACA) requirement ...
Breaking Medicine News(10 mins):